Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches
Related Experiment Video
Updated: Jun 16, 2026

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
Published on: October 20, 2020
David Pham1, Varsha Sivalingam1, Helen M Tang1
1Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW 2145, Australia.
Abstract:
Invasive fungal diseases (IFDs) comprise a growing healthcare burden, especially given the expanding population of immunocompromised hosts. Early diagnosis of IFDs is required to optimise therapy with antifungals, especially in the setting of rising rates of antifungal resistance. Molecular techniques including nucleic acid amplification tests and whole genome sequencing have potential to offer utility in overcoming limitations with traditional phenotypic testing. However, standardisation of methodology and interpretations of these assays is an ongoing undertaking. The utility of targeted Aspergillus detection has been well-defined, with progress in investigations into the role of targeted assays for Candida, Pneumocystis, Cryptococcus, the Mucorales and endemic mycoses. Likewise, whilst broad-range polymerase chain reaction assays have been in use for some time, pathology stewardship and optimising diagnostic yield is a continuing exercise. As costs decrease, there is also now increased access and experience with whole genome sequencing, including metagenomic sequencing, which offers unparalleled resolution especially in the investigations of potential outbreaks. However, their role in routine diagnostic use remains uncommon and standardisation of techniques and workflow are required for wider implementation.
Insights
Early detection of invasive fungal diseases (IFDs) is crucial for effective antifungal therapy. Molecular diagnostics, including nucleic acid amplification tests and whole genome sequencing, show promise but require standardization for routine use.
Area of Science:
- Medical Mycology
- Molecular Diagnostics
- Infectious Diseases
Background:
- Invasive fungal diseases (IFDs) represent a significant and growing global health challenge.
- Immunocompromised populations are at increased risk, necessitating prompt diagnosis and treatment.
- Rising antifungal resistance underscores the need for improved diagnostic strategies.
Purpose of the Study:
- To review the current landscape and future potential of molecular diagnostic techniques for IFDs.
- To highlight the challenges and opportunities in standardizing these advanced assays.
- To discuss the evolving role of molecular methods in clinical practice.
Main Methods:
- Review of current literature on molecular diagnostics for IFDs.
- Discussion of nucleic acid amplification tests (NAATs) and whole genome sequencing (WGS).
- Analysis of targeted and broad-range PCR assays for fungal pathogens.
Main Results:
- Targeted assays for specific fungi like *Aspergillus* are established.
- Progress is being made in developing assays for *Candida*, *Pneumocystis*, *Cryptococcus*, Mucorales, and endemic mycoses.
- Whole genome sequencing, including metagenomic approaches, offers high resolution for outbreak investigations but requires further standardization for routine diagnostics.
Conclusions:
- Molecular techniques offer significant advantages over traditional methods for IFD diagnosis.
- Standardization of methodology and interpretation is critical for widespread adoption.
- Continued research and development are needed to integrate advanced molecular diagnostics into routine clinical workflows.
More Related Videos
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics
Applications of Molecular Taxonomy
Modern Molecular Taxonomy
Methods of Classification and Identification

